If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 51 - 60 of 270
Short TeRm Intensified Pembrolizumab (KEytruda) and Tivozanib for High-Risk Renal Cell Carcinoma - STRIKE
Objective
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer (STRIKE)
Protocol No
ALLIANCE-A032201-STRIKE
Categories
A Phase 2 Study of Epcoritamab and Rituximab for First-Line Treatment of Follicular Lymphoma
Objective
A phase 2 study of Epcoritamab and Rituximab for first-line treatment of follicular lymphoma.
Protocol No
DFCI-22-702
Categories
A Randomized, Double-Blind, Placebo-Controlled Phase 3b Study to Evaluate the Short- and Long-Term Efficacy and Safety of Dual Targeted Therapy With Intravenous Vedolizumab and Oral Upadacitinib Compared With Intravenous Vedolizumab Monotherapy for t
Objective
Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
Protocol No
GI-TAKEDA-VICTRIVA
Categories
A Phase 2 Study with Combination Chemotherapy (Gemcitabine and Nab-Paclitaxel), Chemokine (C-X-C) Motif Receptor 4 Inhibitor (BL-8040), and Immune Checkpoint Blockade (Cemiplimab) in Metastatic Treatment Naïve Pancreas Adenocarcinoma
Objective
Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma
Protocol No
COLUMBIA-S9513-CHEMO4METPANC
Categories
Single-Arm Study of Toripalimab in Combination with Cisplatin and Gemcitabine in Recurrent Metastatic Nasopharyngeal Carcinoma Systemic Treatment Naïve Participants (TRANSPARENT)
Objective
Study of toripalimab for recurrent metastatic nasopharyngeal carcinoma treatment naive patients
Protocol No
RTOG-FND-3521-CHS-007-01
Categories
A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial of Quizartinib Administered in Combination with Induction and Consolidation Chemotherapy and Administered as Maintenance Therapy in Adult Patients with Newly Diagnosed FLT3-ITD Negative Ac
Objective
Study of quizartinib combined with chemo as maintenance for newly diagnosed AML patients
Protocol No
DAIICHI-AC220-168
Categories
Phase 1 Study to Determine the Safety and Tolerability of Ziftomenib Combinations for the Treatment of KMT2A-Rearranged or NPM1-Mutant Relapsed/Refractory Acute Myeloid Leukemia
Objective
Study of ziftomenib combinations in patients with R/R AML
Protocol No
KURA-KO-MEN-008
Categories
A Non-interventional, Prospective, Multi-country Study Collecting Real-world Data on the Characteristics, Treatment Patterns, and Outcomes of Patients with Amyloid Transthyretin (ATTR) Amyloidosis
Objective
MaesTTRo-ATTR
Protocol No
CVC-AZ-MAESTTRO-ATTR
Categories
A Master Protocol to Evaluate the Long-Term Safety of Pirtobrutinib
Objective
Rollover study of LOXO-BTK-18001 for patients with CLL/SLL or non-hodgkin lymphoma
Protocol No
LILLY-J2N-MC-JZNY
Categories
A Phase 3, Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function after Kidney Transplantation
Objective
Ravulizumab vs Placebo in High Risk DGF after Kidney Transplantation
Protocol No
SURG-ALEXION-AWAKE
Categories